News | November 14, 2025
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Cupid has been allocated approximately 23.4 million units of female condoms per year
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
Subscribe To Our Newsletter & Stay Updated
